Our present rescue experiments further confirmed that siRNA-ETV4 neutralized the promotion of cancer progression induced by miR-29b inhibitor, suggesting that inhibition of ETV4 conferred a suppressive role of miR-29b in CRC progression. The gene discussed is ETV4; the disease is cancer.